FedSearch
Poetry News · @haikubot
953 followers · 10400 posts · Server mastodon.cloud

#muvalaplin #clinicaltrial #lipoproteinA #breakthrough #cinquain #poetry

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
89 followers · 1299 posts · Server med-mastodon.com
Olfactory and Trigeminal Functions in Patients With Multiple Sclerosis: Case-control Study - Full Text View - ClinicalTrials.gov

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
89 followers · 1291 posts · Server med-mastodon.com

A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Scleros...

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
87 followers · 1286 posts · Server med-mastodon.com

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL, MULTICENTER STUDY WITH OPEN-LABEL TREATMENT EXTENSION TO ASSESS THE EFFECT OF MIN-102 ON THE PROGRESSION OF ADRENOMYELONEUROPATHY IN M...

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
85 followers · 1282 posts · Server med-mastodon.com
Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis - Full Text View - ClinicalTrials.gov

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
85 followers · 1280 posts · Server med-mastodon.com

A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by...

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

TrangAston :verified: · @CastlTrAstonDrs
1414 followers · 3015 posts · Server med-mastodon.com
Open media

@nejm In patients with with preserved ejection fraction & , (2.4 mg) led to greater reductions in symptoms & physical limitations and greater improvements in exercise function than placebo. Full STEP-HFpEF
nejm.org/doi/pdf/10.1056/NEJMo

#cardiomastodon #heartfailure #obesity #semaglutide #clinicaltrial

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
85 followers · 1275 posts · Server med-mastodon.com
Current Exercise Approaches in Patients With Multiple Sclerosis - Full Text View - ClinicalTrials.gov

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
85 followers · 1275 posts · Server med-mastodon.com
Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS) - Full Text View - ClinicalTrials.gov

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
85 followers · 1270 posts · Server med-mastodon.com
Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial - Full Text View - ClinicalTrials.gov

Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial

classic.clinicaltrials.gov/ct2

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
84 followers · 1266 posts · Server med-mastodon.com

A PHASE IV MULTICENTER, OPEN-LABEL STUDY EVALUATING B CELL LEVELS IN INFANTS OF LACTATING WOMEN WITH CIS OR MS RECEIVING OCRELIZUMAB – THE SOPRANINO STUDY

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

· @NaturalNews
6209 followers · 31843 posts · Server brighteon.social

#breastcancer #clinicaltrial #KrystalCascetta #BIGpharmaFRAUD

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
83 followers · 1255 posts · Server med-mastodon.com

An open-label, multicenter phase II extension of study 28063 (ATAMS) to obtain long-term follow-up data in patients with relapsing multiple sclerosis treated with atacicept for up to 5 years (ATAMS...

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
83 followers · 1255 posts · Server med-mastodon.com

Multicenter, randomized, double-blind, parallel-group extension to study AC 058B201 to investigate the long-term safety, tolerability, and efficacy of 10, 20, and 40 mg&;day ponesimod, an oral S1P1 ...

clinicaltrialsregister.eu/ctr-

#x2f #mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
83 followers · 1250 posts · Server med-mastodon.com

The Effect of the Dose of PI-2301 on Efficacy, Safety, and Tolerability, in Subjects with the Relapsing Remitting Form of Multiple Sclerosis:
A Phase 2 Randomized, double-blind, four–arm, parallel,...

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
83 followers · 1249 posts · Server med-mastodon.com

AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
83 followers · 1248 posts · Server med-mastodon.com

A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis using interferon-beta 1a (Rebif®) as an...

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
83 followers · 1247 posts · Server med-mastodon.com

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post

TrangAston :verified: · @CastlTrAstonDrs
1368 followers · 2871 posts · Server med-mastodon.com

The prevalence of organ impairment in patients at 6 & 12 months after initial symptoms and links to clinical presentation. Organ impairment persisted in 59% of 331 individuals out of 536 individuals, followed up at 1 year with implications for symptoms, quality of life and longer-term health, signalling the need for prevention and integrated care of LC.
journals.sagepub.com/doi/full/

#IDMastodon #viralimmunology #clinicaltrial #LongCovid #postCOVID19

Last updated 1 year ago
Original post

Gregory MS · @gregoryMS
83 followers · 1240 posts · Server med-mastodon.com

An open-label, adaptive design study in patients with amyotrophic lateral sclerosis (ALS) to characterize safety, tolerability and brain microglia response, as measured by TSPO binding, following m...

clinicaltrialsregister.eu/ctr-

#mschat #Neurology #MultipleSclerosis #clinicaltrial #botsfightms

Last updated 1 year ago
Original post